Belantamab Mafodotin

Category: Cancer

Belantamab Mafodotin Overview

Belantamab mafodotin, sold under the brand name Blenrep, is a medication for the treatment of relapsed and refractory multiple myeloma.[1][3][4][2] The most common adverse reactions include keratopathy (corneal epithelium change on eye exam), decreased visual acuity, nausea, blurred vision, pyrexia, infusion-related reactions, and fatigue.[1][3] Belantamab mafodotin is a humanized IgG1κ monocl...

Read more Belantamab Mafodotin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Belantamab Mafodotin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Belantamab Mafodotin
  • Injection: 2.5mg/kg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Belantamab Mafodotin or a similar ingredient: (1 result)

  • BLENREP Belantamab Mafodotin-blmf

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 9 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA